文献速递血管炎

肉芽肿性多血管炎与显微镜下多血管炎的缓解与低疾病活动度:患病率及对损伤累积的影响

Remission and Low Disease Activity in Granulomatosis With Polyangiitis and Microscopic Polyangiitis: Prevalence and Impact on Damage Accrual.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2022-12-21

纳入2个中心随访≥5年的167例肉芽肿性多血管炎(GPA)和显微镜下多血管炎(MPA)患者,评估不同疾病活动水平对损伤累积的影响。超过60%患者达到持续缓解,持续缓解与更好的长期结局相关;持续低疾病活动度(LDAS)与损伤累积增加相关,不是充分的治疗目标。

要点

  • 167例GPA/MPA患者中,10例(6.0%)达到持续完全缓解,89例(53.3%)达到持续治疗中临床缓解。
  • 未达到持续缓解者5年VDI评分高于达到者(3.7±2.0 vs 2.2±1.9,P<0.0001)。
  • 基线耳鼻喉受累(P=0.006)和肺部受累(P=0.047)是持续缓解的负向预测因素。

核心结论

  • 超过60%的GPA/MPA患者达到持续缓解,持续缓解与更好的长期结局相关。
  • 持续LDAS与损伤累积增加相关,不是充分的治疗目标。

研究设计与样本

  • 在2个不同中心纳入随访≥5年的GPA和MPA患者。
  • 采用伯明翰血管炎活动性评分(BVAS)评估疾病活动,采用血管炎损伤指数(VDI)评估损伤。

主要发现

  • 共纳入167例患者:GPA 128例(76.6%),MPA 39例(23.4%),平均年龄51.0±16.7岁。
  • 5年随访期间,10例(6.0%)达到持续完全缓解,6例(3.6%)达到持续停治疗临床缓解,89例(53.3%)达到持续治疗中临床缓解,42例(25.1%)达到持续LDAS,20例(12.0%)从未达到LDAS。
  • 5年VDI评分随疾病活动目标水平升高(完全缓解、停治疗临床缓解、治疗中临床缓解、LDAS)而逐渐恶化。
  • 未达到持续缓解者5年VDI评分高于达到者(3.7±2.0 vs 2.2±1.9,P<0.0001)。
  • 多因素分析显示,基线耳鼻喉受累(P=0.006)和肺部受累(P=0.047)是持续缓解的负向预测因素。

关键数值与推荐

  • 完全缓解定义为BVAS=0、抗中性粒细胞胞质抗体(ANCA)阴性、停止治疗。
  • 停治疗临床缓解定义为BVAS=0、ANCA阳性。
  • 治疗中临床缓解定义为BVAS=0、ANCA阴性或阳性、糖皮质激素≤5 mg/天和/或免疫抑制剂。
  • LDAS定义为0<BVAS≤3、低剂量糖皮质激素(≤7.5 mg/天)和/或免疫抑制剂。
  • 缓解或LDAS持续≥连续2年定义为持续。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the prevalence and impact on damage accrual of different levels of disease activity in patients with granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA). METHODS: Patients with GPA and MPA followed for ≥5 years in 2 different centers were included. Disease activity and damage were assessed using the Birmingham Vasculitis Activity Score (BVAS) and Vasculitis Damage Index (VDI), respectively. Three levels of remission were defined: complete remission (BVAS = 0, negative for antineutrophil cytoplasmic antibody [ANCA], off treatment), clinical remission off therapy (CROffT; BVAS = 0, positive for ANCA), and clinical remission on therapy (CROnT; BVAS = 0, negative or positive for ANCA, glucocorticoids ≤5 mg/day and/or immunosuppressant). A low disease activity state (LDAS) was defined as 0 < BVAS ≤3, low-dose glucocorticoids (≤7.5 mg/day), and/or immunosuppressant. Remission or LDAS were defined as prolonged when lasting ≥2 consecutive years. RESULTS: A total of 167 patients were included: 128 (76.6%) with GPA, 39 (23.4%) with MPA, mean ± SD age 51.0 ± 16.7 years. During a 5-year follow-up, 10 patients (6.0%) achieved prolonged complete remission, 6 (3.6%) prolonged CROffT, 89 (53.3%) prolonged CROnT, 42 (25.1%) prolonged LDAS, and 20 (12.0%) never achieved LDAS. The VDI score at 5 years progressively worsened according to increasing levels of disease activity targets (complete remission, CROffT, CROnT, and LDAS). The mean ± SD 5-year VDI score was higher in patients not achieving prolonged remission compared to those who did (3.7 ± 2.0 versus 2.2 ± 1.9; P < 0.0001). By multivariate analysis, baseline ear, nose, and throat (P = 0.006), and lung involvement (P = 0.047) were negative predictors of prolonged remission. CONCLUSION: More than 60% of patients with GPA/MPA achieved prolonged remission, which was associated with better long-term outcomes. In contrast, prolonged LDAS correlated with increased damage accrual and was not a sufficient treatment target.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Delvino P, Sardanelli F, Monti S, et al. Remission and Low Disease Activity in Granulomatosis With Polyangiitis and Microscopic Polyangiitis: Prevalence and Impact on Damage Accrual. Arthritis Care Res (Hoboken). 2022. PMID: 35604889. doi:10.1002/acr.24958

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。